1. Home
  2. PGEN vs AERO Comparison

PGEN vs AERO Comparison

Compare PGEN & AERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$6.86

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

AERO

Grupo Aeromexico S.A.B.

N/A

Current Price

$14.56

Market Cap

2.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
PGEN
AERO
Founded
1998
1934
Country
United States
Mexico
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
PGEN
AERO
Price
$6.86
$14.56
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$8.33
$28.57
AVG Volume (30 Days)
6.2M
295.1K
Earning Date
05-13-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$11.85
Revenue Next Year
$81.04
$4.57
P/E Ratio
$231.00
$7.95
Revenue Growth
N/A
N/A
52 Week Low
$2.99
$12.26
52 Week High
$7.72
$23.05

Technical Indicators

Market Signals
Indicator
PGEN
AERO
Relative Strength Index (RSI) 55.27 42.99
Support Level $3.96 $13.15
Resistance Level $7.32 $16.84
Average True Range (ATR) 0.39 0.68
MACD -0.07 0.01
Stochastic Oscillator 51.38 43.85

Price Performance

Historical Comparison
PGEN
AERO

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About AERO Grupo Aeromexico S.A.B.

Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.

Share on Social Networks: